Updating results
153 results for kidney cancer Sort: Relevance | Date
Renal cancer overview Kidney conditions Patient experience in adult NHS services Your responsibility when using NICE advice Renal cancer About What is covered This interactive flowchart covers renal cancers. Updates Updates to this interactive
Evidence-based recommendations on percutaneous radiofrequency ablation for treating renal (kidney) cancer
Evidence-based recommendations on irreversible electroporation (IRE) for treating renal (kidney) cancer
Evidence-based recommendations on laparoscopic cryotherapy (keyhole surgery to destroy cancer cells by freezing) for treating renal (kidney) cancer
Evidence-based recommendations on percutaneous cryotherapy for renal (kidney) cancer
This guidance has been updated and replaced by percutaneous radiofrequency ablation for renal cancer
...outcomes of percutaneous cryotherapy for renal cancer in the long term is encouraged. Further...cryotherapy with those of other treatments for renal cancer. Any explanatory notes(if applicable...guidance Percutaneous cryotherapy for renal cancer Number IPG402 Date issued July 2011...
...and efficacy of irreversible electroporation for treating renal cancer is inadequate in quantity and quality. Therefore, this...Comes from guidance Irreversible electroporation for treating renal cancer Number IPG443 Date issued February 2013 Other details Is...
Evidence-based recommendations on nivolumab (Opdivo) for previously treated advanced renal cell carcinoma (RCC/kidney cancer) in adults
Evidence-based recommendations on axitinib (Inlyta) for treating advanced renal cell carcinoma (RCC) (kidney cancer) when prior systemic treatment has failed
Evidence-based recommendations on everolimus (Afinitor) for advanced renal cell carcinoma (kidney cancer) after previous treatment
Evidence-recommendations on erythropoiesis-stimulation agents (epoetin alfa, beta, theta and zeta and darbepoetin alfa) for anaemia in people with cancer..
People with kidney cancer set to benefit from a new innovative immunotherapy, after NICE says it should be available on the NHS.
Patients with advanced kidney cancer will have routine NHS access to the drug everolimus following recommendations by NICE, rather than apply to the Cancer Drugs Fund (CDF).
Evidence-based recommendations on evacizumab (Avastin), soradenib (Nexavar), sunitinib (Sutent) and temsirolimus (Torisel) for renal cell carcinoma
Evidence-based recommendations on sunitinib (Sutent) for the first-line treatment of advanced and/or metastatic renal cell carcinoma
Evidence-based recommendations on pazopanib (Votrient) for the first-line treatment of advanced renal cell carcinoma (RCC/kidney cancer)
This interactive flowchart covers kidney conditions, including pelviureteric junction obstruction, renal cysts and renal stones. It also includes links to the flowcharts on acute kidney injury, anaemia management in people with chronic kidney
Evidence-based recommendations on the assessment and management of chronic kidney disease (CKD) in adults
Evidence-based recommendations on the diagnosis and management of bladder cancer in adults
...cell transplantation for haematological cancers Benralizumab for treating inadequately...gastric or gastro-oesophageal junction cancer Pembrolizumab for locally advanced or...gastric or gastro-oesophageal junction cancer Suggested remit To appraise the clinical...gastric or gastro-oesophageal junction cancer. Consultation on suggested remit, draft scope and...cell transplantation for haematological cancers Suggested remit To appraise the clinical...
Evidence-based recommendations on integrated diagnostics reporting and improving services, staffing and care for people with haematological cancer
Evidence-based recommendations on abiraterone (Zytiga) for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated in adults.
Evidence-based recommendations on the recognition and referral of suspected cancer in children, young people and adults.
Evidence-based recommendations on pemetrexed (Alimta) for locally advanced or metastatic non-squamous non-small-cell lung cancer in adults who have had..
The time taken to diagnose certain common cancers, from the point when a patient first reports a possible symptom to their GP, fell in adults by an average of five days, following the launch of NICE guidelines on cancer referral.
Evidence-based recommendations on anaemia management in people with chronic kidney disease (CKD).
Evidence-based statements to deliver quality improvements in the prevention, detection and management of non-traumatic acute kidney injury (AKI)
NICE has published draft guidance saying the cost of using nivolumab to treat head and neck cancer is too high for routine NHS use.
Patients will have routine access to more cancer drugs as companies have dropped their prices as part of the reformed Cancer Drugs Fund (CDF) process.
This interactive flowchart covers the diagnosis and management of metastatic malignant disease of unknown primary origin.Most patients with newly diagnosed cancer are found to have a clearly defined primary tumour after initial investigation and
Evidence-based recommendations on irreversible electroporation (IRE) for treating primary lung cancer and metastases in the lung
Evidence-based recommendations on irreversible electroporation (IRE) for treating primary liver cancer
Evidence-based recommendations on maintaining a healthy weight and preventing excess weight gain among adults and children.
Evidence-based recommendations on preventing and managing neutropenic sepsis in people with cancer who are having anticancer treatment
Evidence-based recommendations on topotecan (Hycamtin) for treating recurrent stage IVB (stage 4B) cervical cancer (cancer of the cervix)
Evidence-based recommendations on pemetrexed disodium (Alimta) for the first-line treatment of non-small-cell lung cancer (NSCLC)
In development [GID-TAG396] Expected publication date: TBC
Evidence-based recommendations on the prevention, detection and management of acute kidney injury (AKI)
This interactive flowchart covers urogenital conditions, including gynaecological, male genital and urological conditions. It also includes links to interactive flowcharts on cervical cancer, heavy menstrual bleeding, ovarian cancer, prostate
This guidance has been updated and replaced by laparoscopic cryotherapy for renal cancer
Evidence-based recommendations on managing intravenous (IV) fluids for children and young people under 16 years.
Evidence-based recommendations on laparoscopic nephrectomy (including nephroureterectomy; keyhole surgery to remove a kidney)
Evidence-based recommendations on machine perfusion systems and cold static storage of kidneys from deceased donors
Evidence-based recommendations on dabigatran etexilate (Pradaxa) for treatment and secondary prevention of deep vein thrombosis (DVT) or pulmonary embolism
In development [GID-TA10075] Expected publication date: 09 August 2017
In development [GID-TA10123] Expected publication date: 27 December 2017
In development [GID-TA10125] Expected publication date: 27 December 2017
In development [GID-TAG526] Expected publication date: TBC
Evidence-based recommendations on the diagnosing and managing of myeloma in people aged 16 and over.